In Brief: FDA "imminent hazard" criteria
This article was originally published in The Tan Sheet
Executive Summary
FDA "imminent hazard" criteria: Agency determines in final rule published July 23 to retain Sec. 25 in the Code of Federal Regulations describing the criteria FDA would use in determining whether an imminent hazard exists. The agency proposed revoking the section in an Aug. 21, 1979 notice, withdrew the proposed rule on Jan. 20, 1994, then reproposed it in 1996. FDA is retaining the section because the term "imminent hazard" appears in several provisions of the FD&C Act and its implementing regs, including provisions on adulterated dietary supplements, and continued guidance in interpreting the provisions is thought necessary...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning